| Dr David L Gano, MD | |
|
2517 Ne Kresky Ave, Chehalis, WA 98532-2409 | |
| (360) 748-8632 | |
| (360) 807-7687 |
| Full Name | Dr David L Gano |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 31 Years |
| Location | 2517 Ne Kresky Ave, Chehalis, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891862769 | NPI | - | NPPES |
| 1056090 | Medicaid | WA | |
| 1891862769 | Medicaid | MT | |
| 807850800 | Medicaid | ID | |
| 244205 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD00048719 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Cataract And Laser Institute Of Alaska Inc Pc | 4486549300 | 13 |
| Pacific Cataract And Laser Institute Inc Pc | 7517864119 | 73 |
| Pacific Cataract And Laser Institute Inc Pc | 7517864119 | 73 |
| Pacific Cataract And Laser Institute Inc Pc | 7517864119 | 73 |
| Pacific Cataract And Laser Institute Inc Pc | 7517864119 | 73 |
News Archive
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today in Blood, the Journal of the American Society of Hematology (ASH).
Studies of the microbiome in the human gut focus mainly on bacteria. Other microbes that are also present in the gut - viruses, protists, archaea, and fungi - have been largely overlooked.
Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The University of Texas M. D. Anderson Cancer Center reported at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference.
› Verified 5 days ago
| Entity Name | Pacific Cataract And Laser Institute Of Alaska Inc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548213077 PECOS PAC ID: 4486549300 Enrollment ID: O20040224000837 |
News Archive
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today in Blood, the Journal of the American Society of Hematology (ASH).
Studies of the microbiome in the human gut focus mainly on bacteria. Other microbes that are also present in the gut - viruses, protists, archaea, and fungi - have been largely overlooked.
Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The University of Texas M. D. Anderson Cancer Center reported at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David L Gano, MD Po Box 1506, Chehalis, WA 98532-0409 Ph: (360) 242-3008 | Dr David L Gano, MD 2517 Ne Kresky Ave, Chehalis, WA 98532-2409 Ph: (360) 748-8632 |
News Archive
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today in Blood, the Journal of the American Society of Hematology (ASH).
Studies of the microbiome in the human gut focus mainly on bacteria. Other microbes that are also present in the gut - viruses, protists, archaea, and fungi - have been largely overlooked.
Eighteen single-point genetic variations indicate risk of recurrence for early-stage head and neck cancer patients and their likelihood of developing a second type of cancer, researchers at The University of Texas M. D. Anderson Cancer Center reported at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference.
› Verified 5 days ago
Dr. Gordon E Johns, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-807-7687 | |
Dr. Rochelle Deanne Cochrane, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Avenue, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 | |
Dr. Robert Orland Ford, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 | |
Dr. Paul Y Chung, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 | |
Ronald K Sugiyama, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 | |
Dr. Robert Marshall Ford, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 | |
Dr. Jason Leng, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 |